| |
|
|
| |
|
|
| |
Barbara A. Jantausch, MD
|
|
 |
Center of Excellence, Departments, and Programs
The Center for Hospital-based Specialties
Infectious Disease
Children’s Research Institute (CRI)
Center for Clinical and Community Research
View CRI Profile for Barbara A. Jantausch
|
|
| Board Certifications |
American Board of Pediatrics/Infectious Disease
American Board of Pediatrics
|
National Provider Identifier
 |
1255418737 |
| E-Mail |
bjantaus@cnmc.org |
|
| Practice Locations |
Children's National Medical Center - Main Hospital
111 Michigan Avenue, NW
Washington, DC
Phone: 202-476-5000
 
|
|
| Biography |
| Barbara Jantausch, MD, is a pediatric infectious disease specialist. |
|
| Education |
| Type | School | Location | Degree | Field of Study | Years | | Undergraduate Education | Upsala College | | Bachelor of Science | | 1977 | | Medical School | University of Medicine and Dentistry of New Jersey | Newark, NJ | Doctor of Medicine | | 1983 |
|
|
| Training |
| Type | Institution | Location | Position | Specialty | Years | | Residency Program | University of Medicine & Dentistry of New Jersey | Newark, NJ | Resident | | 1983 - 1986 | | Fellowship Program | Children's National Medical Center | Washington, DC | Fellow | | 1986 - 1988 |
|
|
| Affiliations and Memberships |
| Title | Institution | Committee / Section | Years | | Chairman | National Institutes of Health (NIH | Safety Monitoring for a Fully Human Monoclonal Ant | 2005 - 2006 | | Member | National Institute of Child and Health Development | Committee on Bioterrorism | 2008 |
|
|
| Research |
| Title | Study Name | Institution | Years | | Principal Investigator | Prospective, Multicenter, Double-Blind, Randomized, Comparative Study | Merck Research Laboratories | 2002 | | | Principal Investigator | Determination of in vitro susceptibility of Penicillin Susceptible and | Merck Research Laboratories | 2001 | | | Principal Investigator | Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus | Pharmacia and Upjohn | 2001 | | | Principal Investigator | Linezolid IV/PO vs. Vancomycin IV for the Treatment of Resistant Gram- | Pharmacia and Upjohn | 2001 | | | Principal Investigator | Linezolid vs. Cefadroxil in the treatment of skin and skin structure | Pharmacia and Upjohn 2000 | 2000 | | | Read more about the research interests of Barbara A. Jantausch |
|
|
| Publications |
Journal Article, Viraraghavan, R., Jantausch, B., Campos, J. (2004), Late-Onset Central Nervous System Shunt Infection with Proprionibacterium Acnes: Diagnosis and Management. , Clinical Pediatrics, 43, 393-397.
Journal Article, Deville, JG., Adler, S., Azimi, P., Jantausch, BA., Beltran, S., Lopez, P., Edge-Padbury, B., Naberhuis-Stehouser, S., Bruss, J. (2003), Linezolid versus Vancomycin In the Treatment of Known/Suspected Resistant Gram-Positive Infections in Neonates., The Pediatric Infectious Disease Journal, 0, 158-163.
Journal Article, Jantausch, BA., Deville, JG., Adler, S., Morfin, MR., Lopez, P., Edge-Padbury, B., Naberhuis-Stebouser, S., Bruss, J. (2003), Linezolid for the Treatment of Children With Bacteremia or Nosocomial Pneumonia Due to Resistant Gram-Positive Bacterial Pathogens. , The Pediatric Infectious Disease Journal, 22, 164-171.
Journal Article, Ayalew, K., Nambiar, S., Yasinskaya, Y., Jantausch, BA. (2003), Carbapenems in Pediatrics. , Therapeutic Drug Monitoring. , 25, 593-599.
Journal Article, Jantausch, BA., O’Donnell, R., Wiedermann, BL (2000), Urinary Interleukin-6 and Interleukin-8 in Children with Urinary Tract Infection, Pediatric Nephrology, 15, 236-240.
Journal Article, Jantausch, BA., O’Donnell, R., Rodriguez, WJ. (2000), Physician Use of a Telephone Access Line for Infectious Disease Consultation. , Archives of Pediatrics and Adolescent Medicine. , 154, 1170-1171.
Journal Article, Jantausch, BA., Hull, SI. (1996), Restriction Fragment Length Polymorphism of PCR Amplified papE Gene Products is Correlated with Complete Serotype Among Uropathogenic Escherichia coli Isolates., Microbial Pathogenesis. , 20, 351-360.
Journal Article, Jantausch, BA., Luban, NLC., Duffy, L., Rodriguez, WJ. (1995), Treatment of Disseminated Neonatal Echovirus 11 Infection with Maternal Plasma Transfusion. , The Pediatric Infectious Disease Journal, 14, 154-155.
Journal Article, Jantausch, B., Criss, VR., O’Donnell, R., Wiedermann, B., Majd, M., Rushton, HG., Shirey, RS., Luban, NLC. (1994), Association of Lewis Blood Group Phenotypes with Urinary Tract Infection in Children. , Journal of Pediatrics. , 124, 863-868.
Journal Article, Jantausch, B., Rifai, N., Getson, P., Akram, S., Majd, M., Wiedermann, B. (1994), Urinary N-acetyl-b-glucosaminidase and b-2 microglobulin in the Diagnosis of Urinary Tract Infection in Febrile Infants. , The Pediatric Infectious Disease Journal, 13, 294-299.
For a more comprehensive list of publications for Barbara Jantausch, MD view the National Library of Medicine’s PubMed online database |
|
|
|
|
|
|
